ProCE Banner Activity

Why I Favor Treatments That Prevent Recurrence of Clostridioides Difficile Infection

Clinical Thought

I think appropriate treatment of initial infection is our best opportunity to avoid the cycle of recurrent CDI—and now the guidelines agree.

Released: February 11, 2022

Expiration: February 10, 2023

Share

Faculty

Paul Feuerstadt

Paul Feuerstadt, MD, FACG, AGAF

Assistant Clinical Professor of Medicine
Attending Gastroenterologist
Department of Gastroenterology
Yale University School of Medicine
PACT-Gastroenterology Center
Hamden, Connecticut

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Paul Feuerstadt, MD, FACG, AGAF

Assistant Clinical Professor of Medicine
Attending Gastroenterologist
Department of Gastroenterology
Yale University School of Medicine
PACT-Gastroenterology Center
Hamden, Connecticut

Paul Feuerstadt, MD, FACG, AGAF, has disclosed that he has received funds for speakers bureau participation from Ferring, Merck, and Takeda; consulting fees from Ferring; and funds for advisory board participation from Ferring and Takeda.